Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial por Hamaluba, M, Sang, S, Orindi, B, Njau, I, Karanja, H, Kamau, N, Gitonga, J, Mugo, D, Wright, D, Nyagwange, J, Kutima, B, Omuoyo, D, Mwatasa, M, Ngetsa, C, Agoti, C, Cheruiyot, S, Nyaguara, A, Munene, M, Mturi, N, Oloo, E, Ochola-Oyier, L, Mumba, N, Mauncho, C, Namayi, R, Davies, A, Tsofa, B, Nduati, E, Aliyan, N, Kasera, K, Etyang, A, Boyd, A, Hill, A, Gilbert, S, Douglas, A, Pollard, A, Bejon, P, Lambe, T, Warimwe, G

Low-dose yellow fever vaccine in adults in Africa por Kimathi, D, Juan-Giner, A, Bob, NS, Orindi, B, Namulwana, ML, Diatta, A, Cheruiyot, S, Fall, G, Dia, M, Hamaluba, MM, Nyehangane, D, Karanja, HK, Gitonga, JN, Mugo, D, Omuoyo, DO, Hussein, M, Oloo, E, Kamau, N, Wafula, J, Bendera, J, Silvester, N, Mwavita, J, Joshua, M, Mwendwa, J, Agababyona, C, Ngetsa, C, Aisha, N, Moki, F, Buluku, T, Munene, M, Mwanga-Amumpaire, J, Lutwama, J, Kayiwa, J, Kamaara, E, Barrett, AD, Kaleebu, P, Bejon, P, Sall, AA, Grais, RF, Warimwe, GM